Friday, Sep 4, 2026 · SEC filings
What the smart money revealed on Sep 4
415 insider filings came in. We hid 68 planned (10b5-1) sellers and 237 people whose filings were routine, like grants and tax withholding.
Liberty Latin America (LILA) Director Alfonso De Angoitia bought $9.98M
476,190 shares on the open market. Not a grant or an option exercise.
MSCI (MSCI) Director Rajat Taneja bought $1M
1,786 shares on the open market. Not a grant or an option exercise.
Atara Biotherapeutics (ATRA) Director Brian Cherry bought $1000K
104,166 shares on the open market. Not a grant or an option exercise.
Enovis CORP (ENOV) CEO Damien McDonald bought $250K
13,035 shares on the open market. Not a grant or an option exercise.
Illumina (ILMN) Director Keith Meister sold $57.2M
Not marked as a planned 10b5-1 sale. Sold 25% of the shares they held directly. Still holds 770,350 shares.
Caris Life Sciences (CAI) President David Spetzler sold $14.8M
Not marked as a planned 10b5-1 sale. Sold 36% of the shares they held directly. Still holds 1.05M shares.
BILL (BILL) CEO Rene Lacerte sold $12.5M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
13F season
Holdings as of Jun 30, 2026 are due Aug 14
8,899 funds have filed so far. 8,900 filed for the quarter before.
Biggest real insider buys this week
Open-market buys by officers and directors, filed in the 7 days up to Sep 4.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.